Endotronix 2

FDA Approval for Endotronix Pivotal Trial.

Dublin, Ireland and Lisle, Illinois, USA.  August 1, 2019.  Seroba’s portfolio company, Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin the multi-center PROACTIVE-HF trial […]

FDA Approval for Endotronix Pivotal Trial. Read More »